ARCHIVES

House Measure Would Eliminate AHRQ, Rescind PCORI, Cut Outcomes Research, And Halt NIH’s Title 42 Hiring Program

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

Cold Spring Harbor Joins SWOG, Becoming First Lab To Join Cooperative Group

November 4, 2011

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007

ACS To Implement Cancer Response Systems Nationwide

August 2, 1985

Murphy Puts RPMI On Record

July 22, 1977

Research Training – On The Road Back, With Trainee Stipends, Payback Feature

June 14, 1974